CAS: 1788044-12-1 - Carbamic acid, N-1-azaspiro[3.3]hept-6-yl-, 1,1-dimethylethyl ester, hydrochloride (1:1)
Formula:C11H20N2O2.ClH
InChI:InChI=1S/C11H20N2O2.ClH/c1-10(2,3)15-9(14)13-8-6-11(7-8)4-5-12-11;/h8,12H,4-7H2,1-3H3,(H,13,14);1H
InChI key:InChIKey=NOTAIHJBPKQTMR-UHFFFAOYSA-N
SMILES:Cl.O=C(OC(C)(C)C)NC1CC2(NCC2)C1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | tert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate hydrochloride REF: IN-DA00HZWXCAS: 1788044-12-1 | - - - | To inquire | Tue 03 Dec 24 |
 | 6-(Boc-amino)-1-Azaspiro[3.3]heptane HCl REF: 3D-NWC04412CAS: 1788044-12-1 | Min. 95% | To inquire | Tue 14 Jan 25 |
 | TERT-BUTYL 1-AZASPIRO[3.3]HEPTAN-6-YLCARBAMATE HCL REF: 10-F505039CAS: 1788044-12-1 | 95.0% | - - - | Discontinued product |
![tert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate hydrochloride](https://static.cymitquimica.com/products/IN/thumb/DA00HZWX.jpg)
tert-Butyl 1-azaspiro[3.3]heptan-6-ylcarbamate hydrochloride
CAS:1788044-12-1
Formula:
C11H21ClN2O2
Molecular weight:
248.7496
Ref: IN-DA00HZWX
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 3 Dec 2024
![6-(Boc-amino)-1-Azaspiro[3.3]heptane HCl](https://static.cymitquimica.com/products/3D/thumb/NWC04412.jpg)
6-(Boc-amino)-1-Azaspiro[3.3]heptane HCl
CAS:1788044-12-1
Please enquire for more information about 6-(Boc-amino)-1-Azaspiro[3.3]heptane HCl including the price, delivery time and more …
Formula:
C11H21ClN2O2
Purity:
Min. 95%
Molecular weight:
248.75 g/mol
Ref: 3D-NWC04412
| 500mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
![TERT-BUTYL 1-AZASPIRO[3.3]HEPTAN-6-YLCARBAMATE HCL](https://static.cymitquimica.com/products/10/thumb/F505039.jpg)
TERT-BUTYL 1-AZASPIRO[3.3]HEPTAN-6-YLCARBAMATE HCL
CAS:1788044-12-1
Purity:
95.0%
Color and Shape:
Liquid
Molecular weight:
248.75
Ref: 10-F505039
| 1g | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
